Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
04 02 2022
Historique:
entrez: 2 2 2022
pubmed: 3 2 2022
medline: 9 2 2022
Statut: ppublish

Résumé

Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic

Identifiants

pubmed: 35108055
doi: 10.1126/sciadv.abl8920
pmc: PMC8809683
doi:

Substances chimiques

Carbolines 0
GPI-Linked Proteins 0
Piperazines 0
RSL3 compound 0
Receptors, Glucocorticoid 0
erastin 0
Dexamethasone 7S5I7G3JQL
Dipeptidases EC 3.4.13.-
dipeptidase 1 EC 3.4.13.19
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabl8920

Références

Trends Mol Med. 2021 Feb;27(2):113-122
pubmed: 32958404
Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F701-F710
pubmed: 29638160
Nat Nanotechnol. 2016 Nov;11(11):977-985
pubmed: 27668796
Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F385-94
pubmed: 26672618
Neurochem Int. 2017 Mar;104:34-48
pubmed: 28082232
Cell. 2019 Aug 22;178(5):1205-1221.e17
pubmed: 31442408
Nat Cell Biol. 2014 Dec;16(12):1180-91
pubmed: 25402683
Oncotarget. 2015 Sep 15;6(27):24393-403
pubmed: 26405158
Kidney Int. 1988 Apr;33(4):843-9
pubmed: 3386136
Am J Physiol Renal Physiol. 2018 May 1;314(5):F702-F714
pubmed: 28515173
Biochemistry. 1996 Sep 24;35(38):12511-7
pubmed: 8823187
J Cell Mol Med. 2019 Jun;23(6):4153-4164
pubmed: 30993878
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Lab Invest. 1977 Apr;36(4):395-401
pubmed: 66416
Cell. 2019 May 16;177(5):1262-1279.e25
pubmed: 31056284
J Am Soc Nephrol. 2013 Oct;24(10):1545-57
pubmed: 23833261
Free Radic Biol Med. 2021 Oct;174:12-27
pubmed: 34324979
Lancet Oncol. 2019 Mar;20(3):e142-e154
pubmed: 30842058
Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16836-41
pubmed: 25385600
Br J Haematol. 2016 Apr;173(1):13-24
pubmed: 26729065
Antimicrob Agents Chemother. 1982 Jul;22(1):62-70
pubmed: 7125632
Cell Death Dis. 2018 May 22;9(6):595
pubmed: 29789532
Genome Biol. 2014;15(12):550
pubmed: 25516281
Joint Bone Spine. 2011 Jan;78(1):41-4
pubmed: 20471889
Mol Cell Biochem. 1999 Dec;202(1-2):31-6
pubmed: 10705992
Cytogenet Cell Genet. 1992;59(4):258-60
pubmed: 1544318
J Clin Invest. 2018 Jul 2;128(7):2894-2913
pubmed: 29863495
J Clin Invest. 2019 Feb 26;129(6):2293-2304
pubmed: 30830879
J Biol Chem. 2012 Feb 10;287(7):4552-61
pubmed: 22170048
Physiol Rev. 2019 Oct 1;99(4):1765-1817
pubmed: 31364924
Curr Opin Ophthalmol. 2020 Jan;31(1):3-9
pubmed: 31688227
Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22269-22274
pubmed: 31611400
Cell Death Dis. 2020 Mar 17;11(3):192
pubmed: 32184394
Mol Cell. 2015 Jul 16;59(2):298-308
pubmed: 26166707
Front Physiol. 2018 Jul 20;9:964
pubmed: 30079033
Mol Psychiatry. 2017 Nov;22(11):1520-1530
pubmed: 28886009
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Stroke. 2017 Apr;48(4):1033-1043
pubmed: 28250197
Nat Commun. 2021 Jul 20;12(1):4402
pubmed: 34285231
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Arch Dis Child. 1993 Nov;69(5 Spec No):505-9
pubmed: 8285754
J Am Soc Nephrol. 2020 Feb;31(2):280-296
pubmed: 31767624
Endocrine. 2012 Apr;41(2):183-90
pubmed: 22169965
Biochem J. 1997 Aug 15;326 ( Pt 1):47-51
pubmed: 9337849
Nat Cell Biol. 2020 Sep;22(9):1042-1048
pubmed: 32868903
J Am Soc Nephrol. 2017 Jan;28(1):218-229
pubmed: 27352622
Cold Spring Harb Protoc. 2016 Mar 01;2016(3):pdb.prot087395
pubmed: 26933245
Lancet. 2017 Dec 17;388(10063):3006-3016
pubmed: 27871759
Genetics. 2007 Mar;175(3):1137-51
pubmed: 17179087
Nat Commun. 2021 Aug 23;12(1):5078
pubmed: 34426578
J Clin Invest. 2019 Nov 1;129(11):5033-5049
pubmed: 31437128
J Clin Invest. 2013 Oct;123(10):4423-34
pubmed: 24018561
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2672-2680
pubmed: 30692261

Auteurs

Anne von Mässenhausen (A)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Nadia Zamora Gonzalez (N)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Francesca Maremonti (F)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Alexia Belavgeni (A)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Wulf Tonnus (W)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Claudia Meyer (C)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Kristina Beer (K)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Monica T Hannani (MT)

Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, Aachen 52074, Germany.
Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.

Arthur Lau (A)

Department of Medicine, University of Calgary, Calgary, Canada.
Snyder Institute for Chronic Disease, University of Calgary, Calgary, Canada.

Mirko Peitzsch (M)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstrasse 74, Dresden 01307, Germany.

Paul Hoppenz (P)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Sophie Locke (S)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Triantafyllos Chavakis (T)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Fetscherstrasse 74, Dresden 01307, Germany.

Rafael Kramann (R)

Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, Aachen 52074, Germany.
Department of Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, 3015 GD Rotterdam, Netherlands.

Daniel A Muruve (DA)

Department of Medicine, University of Calgary, Calgary, Canada.
Snyder Institute for Chronic Disease, University of Calgary, Calgary, Canada.

Christian Hugo (C)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.

Stefan R Bornstein (SR)

Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Diabetes and Nutritional Sciences, King's College London, London, UK.
Center for Regenerative Therapies, Technische Universität Dresden, Dresden, Germany.
Paul Langerhans Institute Dresden of Helmholtz Centre Munich at University Clinic Carl Gustav Carus of TU Dresden Faculty of Medicine, Dresden, Germany.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Andreas Linkermann (A)

Division of Nephrology, Department of Internal Medicine 3, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.
Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH